Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Apr 6, 2023; 11(10): 2260-2266
Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2260
Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2260
Unilateral contrast-induced encephalopathy with contrast medium exudation: A case report
Zhi-Yuan Zhang, Pei-Jian Wang, Li-Yong Zhang, Ji-Yue Wang, Ji-Heng Hao, Department of Neurosurgery, Liaocheng People’s Hospital, Liaocheng 252001, Shandong Province, China
Hang Lv, School of Clinical Medicine, Weifang Medical University, Weifang 261053, Shandong Province, China
Dan-Yang Zhao, Department of Neurology, Shenyang First People’s Hospital, Shenyang 110041, Liaoning Province, China
Author contributions: Zhang ZY contributed to conception and design of experiments, implementation of research, collection of data, analysis/interpretation of data, and drafting articles; Lv H contributed to conduct research, analyze/interpret data, and draft articles; Wang PJ contributed to collect data and draft articles; Zhao DY contributed to analyze/interpret data, draft articles, and critical review of the intellectual content of articles; Zhang LY contributed to work support, access to research funding, guidance, and supportive contributions; Wang JY contributed to work support, access to research funding , guidance, and supportive contributions; Hao JH contributed to conception and design of experiments, guidance, and supportive contributions.
Informed consent statement: Informed written consent was obtained from the patients for the publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ji-Heng Hao, Doctor, Professor, Department of Neurosurgery, Liaocheng People’s Hospital, No. 45 Huashan Road, Economic Development Zone, Dongchangfu District, Liaocheng 252001, Shandong Province, China. haojiheng@163.com
Received: November 3, 2022
Peer-review started: November 3, 2022
First decision: December 26, 2022
Revised: February 8, 2023
Accepted: March 3, 2023
Article in press: March 3, 2023
Published online: April 6, 2023
Processing time: 146 Days and 23.3 Hours
Peer-review started: November 3, 2022
First decision: December 26, 2022
Revised: February 8, 2023
Accepted: March 3, 2023
Article in press: March 3, 2023
Published online: April 6, 2023
Processing time: 146 Days and 23.3 Hours
Core Tip
Core Tip: Contrast-induced encephalopathy (CIE) is a rare disease induced by the injection of contrast agents. In this case, unilateral CIE was caused by a long time of internal carotid arteriogram on left side and a large amount of contrast agent. The onset was misdiagnosed as subarachnoid hemorrhage at an early stage, and he was discharged without sequelae after 18 d of diagnosis and treatment of CIE. The main treatment measures are corticosteroids, dehydration and diuresis, and adequate hydration. Rapid, accurate diagnosis and treatment are critical steps. Whether the follow-up examination using contrast agent can be done should be closely evaluated and fully informed.